Abstract
Each year, around 100,000 people worldwide receive solid organ transplants, and from the day of their surgery to the day they die almost all of them have to take daily immunosuppressant drugs to prevent the body from attacking the new organ. But an experimental procedure in which patients receive some of the donor's bone marrow in addition to the organ hopes to eliminate the need for lifelong drug therapy. Elie Dolgin talks to the scientists who are rejecting the idea of transplantation as usual.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.